1801HK: Innovent licensed in KRAS G12C drug obtained NMPA BTD designation(/);1810 HK: Oppo abruptly abandons development of self-developed chips (-); 3690.HK: A review of Meituan’s in-store strategy
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.